ArticleCellular oncology (Dordrecht, Netherlands)2026

Discover personalized drug opportunity and optimized tumor-infiltrating lymphocyte therapy for rare cancer: an organoid-based whole-journey clinical mapping study in a neuroendocrine cancer patient.

Xinyu Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.